Mesoporous tantalum oxide nanomaterials induced cardiovascular endothelial cell apoptosis via mitochondrial-endoplasmic reticulum stress apoptotic pathway

Yuanyong Jiao,Xiwei Zhang,Hongyu Yang,Hao Ma,Junjie Zou
DOI: https://doi.org/10.1080/10717544.2022.2147251
IF: 6.819
2022-12-20
Drug Delivery
Abstract:Along with its wide range of potential applications, human exposure to mesoporous tantalum oxide nanomaterials (PEG@mTa 2 O 5 ) has substantially risen. Accumulative toxic investigations have shown the PEG@mTa 2 O 5 intake and cardiovascular diseases (CVD). Endothelial cell death is crucial in the onset and development of atherosclerosis. Still, the molecular mechanism connecting PEG@mTa 2 O 5 and endothelium apoptosis remains unclear. Herein, we studied the absorption and toxic action of mesoporous tantalum oxide (mTa 2 O 5 ) nanomaterials with polyethylene glycol (PEG) utilizing human cardio microvascular endothelial cells (HCMECs). We also showed that PEG@mTa 2 O 5 promoted apoptosis in endothelial cells using flow cytometry and AO-EB staining. In conjunction with the ultrastructure modifications, PEG@mTa 2 O 5 prompted mitochondrial ROS production, cytosolic Ca 2+ overload, ΔΨm collapse, and ER stress verified by elevated ER-Tracker staining, upregulated XBP1 and GRP78/BiP splicing. Remarkably, the systemic toxicity and blood compatibility profile of PEG@mTa 2 O 5 can greatly improve successive therapeutic outcomes of NMs while reducing their adverse side effects. Overall, our findings suggested that PEG@mTa 2 O 5 -induced endothelium apoptosis was partially mediated by the activation of the endoplasmic reticulum stress-mitochondrial cascade.
pharmacology & pharmacy
What problem does this paper attempt to address?